Not so simple: latest EU medtech reform proposals reveal complex management and oversight structure
This article was originally published in SRA
Complicated, very complicated. That is, in a nutshell, one of the major criticisms of the suggested compromise amendments to the proposal for a new EU Medical Device Regulation that are due to be voted on tomorrow by the European Parliament’s ENVI committee.
You may also be interested in...
Switzerland’s current economic and trading relationship with the UK is based on its MRA with the EU. So, where does this leave the two countries in trading with one another now each of their relationships with the EU are under threat?
With fewer than a hundred days left before the EU Medical Device Regulations kick in, Medtech Insight’s executive editor Ashley Yeo and managing editor Amanda Maxwell discuss in this week's podcast growing concerns by medtech industry members that they may not be ready in time to comply with the regulations and may inadvertently run afoul of them.
What will the fall-out of political tensions between the EU and Switzerland mean for notified bodies based in Switzerland, and for the future recognition of CE marks granted in one of the most important medtech markets in Europe?